Shear Load In-shoe Plantar Sensing/Strain Analyses and Mapping in Diabetic Foot Ulcers (SLIPSTREAM)

July 14, 2023 updated by: The Leeds Teaching Hospitals NHS Trust
Stain Analysis Mapping of the Plantar surface (STAMP) is a method designed by the University of Leeds to measure 'in-shoe' strain patterns on the plantar surface of the foot. Shear Load Inductive Plantar Sensing (SLIPS) is an insole designed by the University of Leeds to measure plantar shear stress and plantar pressure. This study aims to compare plantar strain using STAMP and plantar shear stress and plantar pressure using SLIPS in two groups of patients with diabetes; high risk patients with a recently healed plantar ulcer and low risk patients (according to the NICE definition).

Study Overview

Status

Active, not recruiting

Detailed Description

Stain Analysis Mapping of the Plantar surface (STAMP) is a method designed by the University of Leeds to measure 'in-shoe' strain patterns on the plantar surface of the foot. The insole comprises a pseudorandom pattern applied to a plastically deformable insole using a temporary tattoo layer. STAMP utilises digital image correlation to track the deformation of the pattern following a period of walking.

Shear Load Inductive Plantar Sensing (SLIPS) is an insole designed by the University of Leeds to measure plantar shear stress and plantar pressure. SLIPS is an insole which integrates 64 tri-axis soft force sensors which simultaneously measures shear stress and pressure. The SLIPS insole has been designed to measure the plantar load of the right foot and due to its size can only be accommodated by a size 8-11 shoe.

The commercial device Pedar (Novel gmbh) will be used as a reference for plantar pressure measurement in both groups.

This study aims to compare plantar strain using STAMP and plantar shear stress and plantar pressure using SLIPS in two groups of patients with diabetes; high risk patients with a recently healed plantar ulcer and low risk patients (according to the NICE definition).

It is hypothesised that patients with a recently healed plantar ulcer with exhibit elevated plantar strain, plantar shear stress and plantar pressure than the low risk group.

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West Yorkshire
      • Leeds, West Yorkshire, United Kingdom, LS9 7TF
        • Leeds Teaching Hospitals NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

DFU group:

Patients with a recently healed plantar ulcer recruited from a specialised Diabetes Limb Salvage Service in a tertiary referral centre.

Low risk group:

Patients with diabetes and low risk for ulceration recruited from the community podiatry service.

Description

DFU group:

Patients will undergo STAMP and Pedar assessment if they fulfil the following criteria.

Inclusion Criteria:

  1. Age >18
  2. A diagnosis of diabetes mellitus
  3. A diagnosis of diabetic peripheral neuropathy
  4. Recently healed plantar ulcer (within the last 3 months)
  5. Able to provide informed consent
  6. Previous open or endovascular revascularisation

SLIPS inclusion criteria:

Patients will also undergo assessment with the SLIPS insole if they fulfil the following inclusion criteria:

  1. Recently healed plantar DFU located on the right foot
  2. The right foot can be accommodated in a size 8-11 shoe
  3. Weight <100kg

Low risk group:

Patients will undergo STAMP and Pedar assessment if they fulfil the following criteria:

  1. Age >18
  2. A diagnosis of diabetes mellitus
  3. Low risk for DFU according to the NICE NG 19 guidelines (no risk factors for ulceration except callus alone)
  4. Able to provide informed consent

Exclusion Criteria:

  1. Unable to mobilise independently 150m without the use of walking aids and thus unable to complete the walking assessments
  2. Previous ipsilateral minor amputation
  3. Previous ipsilateral surgical offloading procedure
  4. Previous contralateral major amputation
  5. Ipsilateral toe pressure <40mmHg

SLIPS assessment inclusion:

  1. The right foot can be accommodated in a size 8-11 shoe
  2. Weight <100kg

Exclusion criteria:

  1. Unable to mobilise independently 150m without the use of walking aids and thus unable to complete the walking assessments
  2. Previous ipsilateral minor amputation
  3. Presence of a foot deformity
  4. Previous contralateral major amputation
  5. Ipsilateral toe pressure <40mmHg

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Diabetic Foot Ulcer (DFU) group

Inclusion criteria:

  1. Age >18
  2. A diagnosis of diabetes mellitus
  3. A diagnosis of diabetic peripheral neuropathy
  4. Recently healed plantar ulcer (within the last 3 months)
Low risk group

Inclusion criteria:

  1. Age >18
  2. A diagnosis of diabetes mellitus
  3. Low risk for DFU according to the NG19 guidelines (no risk factors for ulceration except callus alone)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak plantar strain
Time Frame: At clinical visit on study entry
The difference in peak plantar strain (%) (as measured with STAMP) between the DFU and low risk group
At clinical visit on study entry

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Regional peak plantar strain
Time Frame: At clinical visit on study entry
The difference in regional peak plantar strain (%) between the DFU and low risk group at the 10 pre-specified regions: heel, midfoot, 1st metatarsal head (MTH), 2nd MTH, 3rd MTH, 4th MTH, 5th MTH, hallux, 2nd toe, toes 3-5
At clinical visit on study entry
Regional peak plantar shear
Time Frame: At clinical visit on study entry
The difference in regional peak plantar shear (kPa) between the DFU and low risk group at the 10 pre-specified regions: heel, midfoot, 1st metatarsal head (MTH), 2nd MTH, 3rd MTH, 4th MTH, 5th MTH, hallux, 2nd toe, toes 3-5
At clinical visit on study entry
Peak Plantar pressure
Time Frame: At clinical visit on study entry
Global peak plantar pressure (kPa) between DFU and low risk groups.
At clinical visit on study entry
Regional Peak Plantar pressure
Time Frame: At clinical visit on study entry
Regional peak plantar pressure (kPa) between DFU and low risk groups
At clinical visit on study entry

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David A Russell, University of Leeds

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2022

Primary Completion (Estimated)

April 3, 2024

Study Completion (Estimated)

April 3, 2024

Study Registration Dates

First Submitted

September 28, 2022

First Submitted That Met QC Criteria

January 6, 2023

First Posted (Actual)

January 18, 2023

Study Record Updates

Last Update Posted (Actual)

July 17, 2023

Last Update Submitted That Met QC Criteria

July 14, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetic Foot

Subscribe